In response to a question about what aspect of healthcare or science he finds “most frustrating,” Dr. Collins noted a pet peeve familiar to many physicians — the EHR. “I thought by now we’d be in a circumstance where those would be interoperable and portable, so patients would have easy access to their own records,” he said. “That’s still been very frustrating.”
Ms. Keshavan proceeded to ask which technology has Dr. Collins “most fired up,” to which Dr. Collins responded with a discussion about gene-editing technology, focusing on CRISPR-Cas9, a tool that enables scientists to modify an organism’s DNA.
“I’m very excited about the potential of gene-editing to cure rare diseases for which we know the molecular defect and there’s no current therapy,” he said. “CRISPR-Cas9 has made it possible not just to dream about such protocols, but actually design them. I think this will be the year where we will see the first clinical trials to cure sickle cell disease using CRISPR-Cas9.”
To access Dr. Collins’ interview with STAT, click here.
More articles on EHRs & interoperability:
Allscripts to acquire patient engagement firm HealthGrid for $60M
Few hospitals have implemented ONC’s safety guides for EHRs, study suggests
16 hospitals, health systems seeking Allscripts, Cerner, Epic, Meditech talent
